Abstract
We report a case of Gitelman syndrome presenting with fatigue, paresthesias, weakness of limbs and neck muscles since 2.5 years of age. Investigations showed hypokalemia and hypomagnesemia with urinary magnesium wasting. Genetic analysis revealed the presence of a novel homozygous mutation in the SLC12A3 gene (c.2879_2883+9ins14bp, p.Val 960 Glu fsx12). Management with potassium and magnesium supplements and spironolactone resulted in a significant improvement in symptoms. Over a follow-up of 11 years, the patient showed satisfactory growth and physical development.
Similar content being viewed by others
References
Simon DB, Nelson-Williams C, Bia MJ, Ellison D, Karet FE, Molina AM, et al. Gitelman’s variant of Bartter’s syndrome, inherited hypokalemic alkalosis, is caused by mutations in the thiazide-sensitive Na–Cl cotransporter. Nat Genet. 1996;12:24–30.
Knoers NV. Inherited forms of renal hypomagnesemia: an update. Pediatr Nephrol. 2009;24:697–705.
Peters M, Jeck N, Reinalter S, Leonhardt A, Tonshoff B, Klaus GG, et al. Clinical presentation of genetically defined patients with hypokalemic salt-losing tubulopathies. Am J Med. 2002;112:183–90.
Bettinelli A, Metta MG, Perini A, Basilico E, Santeramo C. Long-term follow-up of a patient with Gitelman’s syndrome. Pediatr Nephrol. 1993;7:67–8.
Herrero-Morín JD, Rodríguez J, Coto E, Gil-Peña H, Alvarez V, Espinosa L, et al. Gitelman syndrome in Gypsy pediatric patients carrying the same intron 9 + 1 G>T mutation. Clinical features and impact on quality of life. Nephrol Dial Transpl. 2011;26:151–5.
Conti G, Vitale A, Tedeschi S, Syrén ML, Pantano R, Chimenz R, et al. Hypokalaemia and failure to thrive: report of a misleading onset. J Paediatr Child Health. 2010;46:276–7.
Pachulski RT, Lopez F, Sharaf R. Gitelman’s not-so-benign syndrome. N Engl J Med. 2005;353:850–1.
http://www.cdc.gov/growthcharts/percentile_data_files.htm (accessed 29 April 2011).
Colussi G, Bettinelli A, Tedeshi S, de Ferrari ME, Syren ML, Borsa N, et al. A thiazide test for the diagnosis of renal tubular hypokalemic disorders. Clin J Am Soc Nephrol. 2007;2:454–60.
Riveira-Munoz E, Chang Q, Godefroid N, Hoenderop JG, Bindels RJ, Dahan K, et al. for the Belgian Network for the Study of Gitelman syndrome. Transcriptional and functional analyses of SLC12A3 mutations: new clues for the pathogenesis of Gitelman syndrome. J Am Soc Nephrol. 2007;18:1271–83.
Takeuchi K, Kure S, Kato T, Taniyama Y, Takahashi N, Ikeda Y, et al. Association of a mutation in thiazide-sensitive Na–Cl cotransporter with familial Gitelman syndrome. J Clin Endocrinol Metab. 1996;81:4496–9.
Lemmink HH, Knoers NV, Karolyi L, van Dijk H, Niaudet P, Antignac C, et al. Novel mutations in the thiazide-sensitive NaCl cotransporter gene in patients with Gitelman syndrome with predominant localization to the C-terminal domain. Kidney Int. 1998;54:720–30.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Sinha, A., Lněnička, P., Basu, B. et al. Gitelman syndrome: novel mutation and long-term follow-up. Clin Exp Nephrol 16, 306–309 (2012). https://doi.org/10.1007/s10157-011-0542-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10157-011-0542-x